Nationwide recall of blood pressure drugs

A nationwide recall has been issued for over 25,000 bottles of Inventia Healthcare's 25 mg chlorthalidone tablets due to improper dissolution, which can affect the drug's effectiveness in lowering blood pressure. The recall includes bottles with specific batch codes and expiration dates, and consumers are advised to consult healthcare providers before stopping or continuing their medication. The FDA classifies the recall as Class II, indicating potential for temporary or reversible health effects.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل